By Prof. Raphael Nyarkotey Obu  In recent times, I have been delving into the potency of attaya in the Gambia. This is partly ...

The locus coeruleus, located deep in the brainstem, is known as the brain’s “blue spot” because it contains a pigment called ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...

A new study maps what healthy aging looks like in a unique brain region that’s often affected early by neurodegenerative ...

The outlook on the prevention, diagnosis and treatment of Alzheimer’s disease is brighter than ever. Backed by decades of ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function.

When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with early-stage disease.

New findings from the EXERT study reveal that both low and moderate-high intensity exercise may help preserve cognitive function in older adults with mild memory problems, a major risk factor for ...

Researchers have mapped age-related changes in the brain’s locus coeruleus (LC), a region linked to cognition and Alzheimer’s ...

In a demographically diverse sample of healthy people, Cornell researchers found dramatic changes over the human lifespan in ...